BioSpace News Archive

Emtora Biosciences, a privately-held, clinical stage life science company announced today that it will receive a SEED Award grant totaling $3 million from the Cancer Prevention and Research Institute of Texas (CPRIT).

Hope & Coffee, a coffee shop in Tamaqua, Pennsylvania that offers people recovering from opioid addiction a fresh start through employment and meeting space, was the site of the panel discussion.

C3® International, Inc., a biopharmaceutical company that has played a leadership role in the emerging cannabinoid therapeutics health sector, today officially announced that HRH Dr. Percy Tamayo is joining the company in the role of Vice President.

CONMED Corporation announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Morgan Stanley 17th Annual Global Healthcare Conference at 1:30 p.m. ET on Tuesday, September 10, 2019 in New York, NY.

Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.

Every day Americans enjoy an abundant food supply that is among the safest in the world. The U.S. Food and Drug Administration works tirelessly to ensure that foods available to consumers, whether they are produced domestically or abroad, meet the FDA’s food safety requirements and that we are using all available tools to ensure compliance.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the company will participate at the upcoming 17th Annual Morgan Stanley Global Healthcare Conference being held from September 9-11, 2019 in New York, NY.

Stability Growth Recognized By High Times Cannabis Cup for Top Indica Flower Cultivation and Top Non-Solvent Concentrate.

By using single-cell analysis to measure metabolic activities in rare disseminated tumor cells taken from non-small cell lung cancer patients, Institute for Systems Biology researchers and their collaborators can accurately predict how patients will respond to various cancer therapies, and how treatments will impact a patient’s physiological performance and survival.

Cognate BioServices announced it has secured a financial sponsor to support its short-term and long-term growth as it closed on a round of growth capital from EW Healthcare Partners.